(Q80089153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

myeloproliferative disorders

28 December 2019

main subject

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

William Vainchenker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Daniel Birnbaum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Lelièvre H

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Cervera N

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Finetti P

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Bertucci F

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

10 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1885-1888

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900207%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404361

28 December 2019

exact match

0 references

cites work

Chronic myeloproliferative disorders: a tyrosine kinase tale.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

Activated Jak2 with the V617F point mutation promotes G1/S phase transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404361

7 January 2021